Mon, September 26 2005 09:00 AM
Nucleofector technology now combined with the world's largest cell line collection
The 
American Type Culture Collection (ATCC) and amaxa have entered into an agreement that will help researchers save valuable time by allowing them to work immediately with optimized and ready-to-use non-viral transfection protocols on a wide range of cell lines.
Mike Gove, VP Marketing and Sales, ATCC, says: »By cross-referencing optimized protocols developed by amaxa with detailed information about cell lines available through ATCC on our websites, amaxa and ATCC are making it easier for researchers to be successful with the innovative Nucleofector technology.«
For more information see our 
press release.
Keep checking our websites to learn more about the collaboration.
»ATCC« is a registered trademark of American Type Culture Collection.
